Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reperfusion revisited

T D Valenzuela

    The Journal of Emergency Medicine
    |January 1, 1993
    PubMed
    Summary
    This summary is machine-generated.

    Thrombolytic therapy offers significant benefits for time-sensitive conditions like acute myocardial infarction (AMI). Proactive collaboration among physicians ensures optimal patient selection and treatment for maximum efficacy and safety.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparative anatomy of the porcine and human thoracic spines with reference to thoracoscopic surgical techniques.

    Surgical endoscopy·2005
    Same author

    Factors associated with CPR certification within an elderly community.

    Resuscitation·2001
    Same author

    Clinical research on out-of-hospital emergency care.

    The New England journal of medicine·2001
    Same author

    Increasing paramedics' comfort and knowledge about children with special health care needs.

    The American journal of emergency medicine·2000
    Same author

    Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos.

    The New England journal of medicine·2000
    Same author

    Use of emergency medical services by children with special health care needs.

    Prehospital emergency care·2000
    Same journal

    Structural Determinants of Telehealth Use Among Patients Presenting to an Urban Safety-Net Emergency Department.

    The Journal of emergency medicine·2026
    Same journal

    Comparison of Over-the-Head and Standard Lateral Cardiopulmonary Resuscitation: A Prospective Crossover Simulation Study.

    The Journal of emergency medicine·2026
    Same journal

    Time-Critical Diagnosis of Pediatric Testicular Torsion in a Tertiary Pediatric Emergency Setting: Integrating Clinical Predictors With Selective Doppler Ultrasound.

    The Journal of emergency medicine·2026
    Same journal

    The Role of Radiological Imaging in Pediatric Nasal Fractures: Too Much, Too Often?

    The Journal of emergency medicine·2026
    Same journal

    Paid Time Off Pressure in Emergency Medicine: Vacation Conflict Risk in the Context of Group Size, and Shift Coverage.

    The Journal of emergency medicine·2026
    Same journal

    Reducing Hyperoxemia in Mechanically Ventilated Emergency Department Patients: A Before-and-After Study.

    The Journal of emergency medicine·2026
    See all related articles

    Area of Science:

    • Thrombolytic therapy
    • Cardiovascular medicine
    • Emergency medicine

    Background:

    • Rapid advancements in thrombolytic treatment have created ambiguity for practicing physicians regarding optimal use.
    • Key questions persist on ideal indications, patient selection, and the choice of thrombolytic agents for various conditions.
    • Experience with thrombolysis in acute myocardial infarction (AMI) provides valuable insights into managing these ambiguities.

    Discussion:

    • Thrombolytic treatment is most effective when initiated early in 'time-sensitive' conditions.
    • Minimizing treatment delays requires proactive consensus among emergency physicians and specialists (cardiology, internal medicine, etc.) on patient and drug selection, and supportive care.
    • Pre-arrival agreement on treatment protocols is crucial to avoid delays and ensure patient safety.

    Related Experiment Videos

    Key Insights:

    • Optimal benefit from thrombolysis is directly linked to the timeliness of treatment initiation.
    • Multidisciplinary collaboration is essential for establishing clear guidelines on patient selection, drug choice, and ancillary therapies.
    • Standardized protocols reduce the risk of complications and inappropriate use of thrombolytic agents.

    Outlook:

    • Establishing clear, pre-agreed protocols for thrombolytic therapy will enhance patient outcomes.
    • Future research should focus on refining patient stratification and optimizing drug selection for diverse thrombotic conditions.
    • Continued interdisciplinary cooperation is vital for maximizing the benefits of thrombolytic treatments.